Pfizer Covid-19 vaccine more than 94% effective in older adults
18th Nov 2020 12:09
(Sharecast News) - The Covid-19 vaccine candidate being developed by Pfizer and BioNTech has shown an elevated degree of efficacy in preventing Covid-19 among those aged 65 and over.
Read moreEurope close: Stocks finish week on up note, despite remaining risks
13th Nov 2020 18:41
(Sharecast News) - European shares finished a week of rampant gains on a positive note, helped by reports that the second wave of Covid-19 cases in Belgium and France might be breaking.
Read moreRising Covid-19 positivity rates in US may require restrictions in large-population states
13th Nov 2020 13:54
(Sharecast News) - Covid-19 test positivity is increasing rapidly and may necessitate that most large-population states impose more severe restrictions, a top-ranked US economist said.
Read moreHSBC upgrades AstraZeneca on vaccine newsflow
11th Nov 2020 11:19
(Sharecast News) - HSBC upgraded AstraZeneca to 'hold' based on stronger commercial delivery and expected further good news about Covid-19 vaccines.
Read moreUK to have 10m doses of Pfizer/BioNTech Covid-19 vaccine by end-2020, if approved
10th Nov 2020 11:06
(Sharecast News) - Britain will have 10m doses of the Covid-19 vaccine being developed by Pfizer and BioNTech by the end of 2020.
Read moreAstraZeneca sees positive results from asthma treatment trial
10th Nov 2020 07:37
(Sharecast News) - AstraZeneca, alongside its partner Amgen, announced positive results from the 'NAVIGATOR' phase 3 trial for the potential new medicine 'tezepelumab' on Tuesday, in patients with severe, uncontrolled asthma.
Read moreAstraZeneca's Calquence receives EU approval
9th Nov 2020 08:38
(Sharecast News) - Pharmaceutical giant AstraZeneca's leukaemia treatment has received European Union approval.
Read moreAstraZeneca's Brilinta approved in the US to reduce risk of stroke
6th Nov 2020 08:07
(Sharecast News) - AstraZeneca said on Friday that its Brilinta drug has been approved in the US to reduce the risk of stroke.
Read moreAstraZeneca on track to meet guidance
5th Nov 2020 07:10
(Sharecast News) - AstraZeneca said it was on track to meet full-year guidance as the drugs company reported slowing revenue growth in the third quarter.
Read moreThursday preview: Bank of England, AstraZeneca in focus
4th Nov 2020 14:45
(Sharecast News) - The focus on Thursday will shift to the Bank of England, which is expected to boost the size of its asset purchase facility by £110bn, followed later in the session by the US Federal Reserve which may also signal that further quantitative easing is in the pipeline.
Read moreDoctors in England on alert for possible Covid-19 vaccine before Christmas
4th Nov 2020 11:29
(Sharecast News) - Doctors in England have been placed on alert for the potential roll-out of a Covid-19 vaccine this side of Christmas.
Read moreAstraZeneca Covid-19 vaccine to be widely distributed by end Q1 2021 - report
2nd Nov 2020 12:32
(Sharecast News) - The Covid-19 vaccine being developed by AstraZeneca and Oxford University could be in advanced stage of distribution by the end of the first quarter of 2021.
Read morePfizer, AstraZeneca Covid-19 vaccine reviews accelerated - report
30th Oct 2020 11:46
(Sharecast News) - Britain's drug regulator has reportedly started an accelerated reviews of Covid-19 vaccines under development from Pfizer and AstraZeneca.
Read moreAstraZeneca sells Atacand rights to Cheplapharm for $400m
30th Oct 2020 07:23
(Sharecast News) - AstraZeneca said it was selling the commercial rights to its heart failure and hypertension drug Atacand and Atacand Plus in around 70 countries globally to Cheplapharm Arzneimittel for $400m.
Read moreAstraZeneca makes regulatory progress with Enhertu and Forxiga
28th Oct 2020 07:35
(Sharecast News) - AstraZeneca, alongside its partner Daiichi Sankyo, said on Wednesday that 'Enhertu', or trastuzumab deruxtecan, has been accepted by the FDA for its supplemental biologics license application (sBLA).
Read more